To Evaluate the Efficacy of intraoperative Dexmedetomidine administration for preventing Delirium in elderly after surgery

Evaluation of Dexmedetomidine on delirium in elderly patients postoperatively:A Randomized Control Trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056358

Enrollment

130

Registered

2023-08-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: dexmedetomidine: dexmedetomidine is infused at the rate of 0.5 mcg/ kg /hr without loading dose after induction till the end of surgery Control Intervention1: 0.9% normal saline: normal

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1 & 2 Surgery-Exploratory Laparotomy under general anaesthesia

Exclusion criteria

Exclusion criteria: ASA Grade 3 & 4 Patients with serious mental illness, patients who already have delirium.

Design outcomes

Primary

Measure	Time frame
To determine whether dexmedetomidine is associated with a decreased incidence of POD among elderly patients.Timepoint: after induction end of surgery postoperative day 1 postoperative day 2 postoperative day 3 postoperative day 4 postoperative day 5	—

Secondary

Measure	Time frame
reduces the occurrence of non delirium postoperative complications shortens length of hospital stay Timepoint: postoperative day 1 postoperative day 2 postoperative day 3 postoperative day 4 postoperative day 5 date of discharge	—

Countries

India

Contacts

Public ContactDr Saurabh Suman

Rajendra Institute of Medical Sciences, Ranchi

shiopriye@gmail.com9986743162

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026